Enliven Therapeutics
ELVN
#3751
Rank
โ‚น317.30 B
Marketcap
โ‚น4,311
Share price
0.26%
Change (1 day)
121.26%
Change (1 year)

Enliven Therapeutics (ELVN) - Total liabilities

Total liabilities on the balance sheet as of June 2026 : โ‚น1.39 Billion

According to Enliven Therapeutics's latest financial reports the company's total liabilities are โ‚น1.39 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Enliven Therapeutics - Total liabilities on balance sheet (from 2021 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31โ‚น1.48 B8.94%
2024-12-31โ‚น1.36 B-36.83%
2023-12-31โ‚น2.16 B-83.69%
2022-12-31โ‚น13.25 B13.96%
2021-12-31โ‚น11.62 B5.08%
2020-12-31โ‚น11.06 B